ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,567.19
      1.06%
      US Tech 100
      19,828.00
      0.95%
      Dow Jones
      39,375.87
      0.17%
      Brent Oil
      86.775
      0.00%
      Bitcoin
      57,701.07
      -1.03%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Precipio Inc (PRPO)

      7. Precipio Inc (PRPO) News

      PRPO

      Precipio (PRPO)

      Precipio Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:PRPO
      DateTimeSourceHeadlineSymbolCompany
      09/28/20239:00AMGlobeNewswire Inc.Precipio Continues to Sign New HemeScreen™ CustomersNASDAQ:PRPOPrecipio Inc
      09/25/202311:00AMGlobeNewswire Inc.Precipio Reduces Product Revenue Result Needed for Cash Flow BreakevenNASDAQ:PRPOPrecipio Inc
      09/21/20235:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRPOPrecipio Inc
      09/14/20234:41PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRPOPrecipio Inc
      09/14/20234:41PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRPOPrecipio Inc
      09/14/20234:40PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRPOPrecipio Inc
      09/14/20234:40PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRPOPrecipio Inc
      09/14/20234:40PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRPOPrecipio Inc
      09/14/20234:39PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRPOPrecipio Inc
      09/13/20239:30AMGlobeNewswire Inc.Precipio’s Pathology Division Exceeds Breakeven Revenues in August, Four Months Ahead of PlanNASDAQ:PRPOPrecipio Inc
      08/14/20234:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRPOPrecipio Inc
      08/11/20234:31PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PRPOPrecipio Inc
      08/10/20235:00PMGlobeNewswire Inc.Precipio Announces Q2-2023 Shareholder Update CallNASDAQ:PRPOPrecipio Inc
      08/08/20239:00AMGlobeNewswire Inc.Precipio Launches Its Much-Anticipated Quantitative BCR-ABL 2.0 PanelNASDAQ:PRPOPrecipio Inc
      08/03/20239:00AMGlobeNewswire Inc.Precipio’s Operational Efficiency Measures Continue To Reduce Cash Burn And Move The Company Towards BreakevenNASDAQ:PRPOPrecipio Inc
      08/01/20239:00AMGlobeNewswire Inc.Precipio Unaudited Q2-2023 Revenues Show combined increase of 25% over Q1-2023NASDAQ:PRPOPrecipio Inc
      07/20/202312:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PRPOPrecipio Inc
      07/07/20234:30PMEdgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:PRPOPrecipio Inc
      06/15/20235:01PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PRPOPrecipio Inc
      06/14/20239:49AMGlobeNewswire Inc.Precipio’s Omnia™ Methodology Enables Diagnosis of MDS With Peripheral Blood Instead of Bone Marrow BiopsyNASDAQ:PRPOPrecipio Inc
      06/13/20239:00AMGlobeNewswire Inc.Precipio Enters into Collaboration with Prestigious New York-based Institution to Develop Revolutionary Brain Tumor Panel using HemeScreen® TechnologyNASDAQ:PRPOPrecipio Inc
      06/12/20234:16PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PRPOPrecipio Inc
      06/09/20234:02PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:PRPOPrecipio Inc
      06/08/20238:30AMGlobeNewswire Inc.Precipio, Inc. Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private PlacementNASDAQ:PRPOPrecipio Inc
      06/07/20239:30AMGlobeNewswire Inc.Projected cash burn reduced by $1.5 million annually from Three Operational Efficiency ProjectsNASDAQ:PRPOPrecipio Inc
      05/22/202311:00AMGlobeNewswire Inc.Precipio’s Lab Detects BCR-ABL1 Oncogene Co-Expression of p190 & p210 Isoforms in a CML Patient By Using HemeScreen® TechnologyNASDAQ:PRPOPrecipio Inc
      05/17/20234:00PMGlobeNewswire Inc.Precipio Shares Growth Catalysts For HemeScreenNASDAQ:PRPOPrecipio Inc
      05/16/20236:02AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PRPOPrecipio Inc
      05/15/20234:00PMGlobeNewswire Inc.Precipio Announces Q1-2023 Shareholder Update CallNASDAQ:PRPOPrecipio Inc
      05/12/20234:08PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PRPOPrecipio Inc
       Showing the most relevant articles for your search:NASDAQ:PRPO

      Your Recent History

      LSE
      89BQ
      07sep2028c
      BOV
      CMIG3
      CEMIG ON
      Delayed Upgrade Clock